Dow Jones Top Company Headlines at 5 AM ET: Baidu Revenue Falls on Weak Advertising Demand, Posts Loss on Impairment | AkzoNobel, ...
Baidu Revenue Falls on Weak Advertising Demand, Posts Loss on Impairment
The Chinese search-engine giant reported lower revenue as advertising demand remained weak, and swung to a quarterly loss, hit by an impairment charge.
----
AkzoNobel, Axalta to Form $17 Billion Paints Giant in All-Stock Merger
The merger is set to create a global coatings giant with a single listing on the New York Stock Exchange following a transition period.
----
Credit Agricole Looks to Europe to Boost Earnings
The bank aims to grow outside its home market under its new three-year plan, adding around six million new customers.
----
First Brands to Tap Examiner to Probe Financial Irregularities
A judge said he would approve an examiner in the bankruptcy case to look into claims of fabricated invoices and double-pledged collateral.
----
U.S. Investigators Probe Exec Facing Fraud Allegations From BlackRock's HPS
Federal officials have opened a criminal investigation into Bankim Brahmbhatt, who was sued by HPS and other lenders earlier this year.
----
What the Netflix Stock Split Means for the Shares
Splits don't change the value of a company, but they are designed to make a stock more affordable for individual investors.
----
Home Depot's Mojo Stalls. Earnings Are a Worry.
Big-box estimates have edged down slightly as foot traffic declines and analysts worry about shoppers losing their appetite.
----
Novo Nordisk Cuts Prices for Obesity Drugs
The Denmark-based company slashed prices for the first two monthly doses of Wegovy and Ozempic for those who pay cash for the treatments between Nov. 17 and March 31.
----
Deutsche Bank Targets Higher Profitability, Cost Savings Through 2028
The German lender is looking to deliver growth in revenue, profitability and returns to shareholders in the period running through to 2028, after years of restructuring under Chief Executive Christian Sewing.
----
Johnson & Johnson to Buy Halda Therapeutics For $3.05 Billion
Johnson & Johnson has agreed to buy clinical-stage biotechnology company Halda Therapeutics for $3.05 billion in cash in a deal that bolsters the healthcare giant's oncology pipeline.
----
Dassault Aviation Rises After Ukraine Agrees to Buy 100 Rafale Fighter Jets
Ukraine agreed to buy 100 Rafale fighter jets as part of a larger military equipment deal that triggered a jump in the share price of the French aerospace and defense manufacturer.
----
Oil Major TotalEnergies Is Betting Big on Electricity
The French company is investing in power plants across Europe, expanding a strategy that has set it apart from rivals focused on pumping more fossil fuels.
----
Gibraltar to Acquire OmniMax International for $1.34 Billion
Gibraltar Industries agreed to acquire roofing-products manufacturer OmniMax International from funds managed by Strategic Value Partners and its affiliates for about $1.34 billion in cash.
(END) Dow Jones Newswires
November 18, 2025 05:15 ET (10:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for November
This Once-Hot AI Stock Now Looks Deeply Undervalued
The 10 Best Companies to Invest in Now
3 of the Best Dividend Stocks to Own
United States